We only have this paper's title and publication details.
Read it at the sourceCombination of navitoclax and survivin inhibitor shows effective tumor growth inhibition in ovarian cancer, indicating potential treatment advancement.
FACs sorting of ALDH populations
No takes yet. Share an insight, caveat, or question.
Kenny et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: